Skip to content

Effect of Intraoperative Infusion of Dexmedetomidine on Postoperative Delirium in Elderly Patients with Frailty--A Prospective, Double-blind, Randomized Clinical Trial

Effect of Intraoperative Infusion of Dexmedetomidine on Postoperative Delirium in Elderly Patients with Frailty--A Prospective, Double-blind, Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103523
Enrollment
Unknown
Registered
2025-05-30
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium (POD)

Interventions

Dexmedetomidine group:Received a loading dose of dexmedetomidine 0.6 µg/kg 10 minutes before induction of anesthesia, followed by a continuous infusion (0.3 µg/kg/h) until 1 hour before the end of sur
Saline solution group:Received a loading dose of saline solution 0.36 ml/kg 10 minutes before induction of anesthesia, followed by continuous infusion (0.03 ml/kg/h) until 1 hour before the end of the

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients who undergo elective non-cardiac and non-neurosurgical procedures under general anesthesia; 2. Frailty was assessed by the Fried frailty phenotype 1 day before surgery; 3. Age>=60 years; 4. Those who can conduct on-site follow-up interviews, can understand and sign the informed consent form and are willing to complete neuropsychological testing; 5. American Society of Anesthesiologists (ASA) Class I-III.

Exclusion criteria

Exclusion criteria: 1. Patient refusal to participate in the study; 2. Dementia, major depressive disorder, or other severe mental or neurological disorders prior to the study; 3. Limb amputation, paraplegia; 4. There are related diseases affecting the muscles of the lower limbs (such as polio, polio, myasthenia gravis, polymyositis, etc.); 5. Heart failure, pulmonary hypertension, respiratory failure, liver and kidney dysfunction; 6. Known preoperative left ventricular ejection fraction less than 30%, sick sinus syndrome, severe sinus bradycardia ( 6 years) MMSE 10 points).

Design outcomes

Primary

MeasureTime frame
Postoperative delirium;

Secondary

MeasureTime frame
Quadriceps thickness;Albumin;Hemoglobin;Quality of recovery;Length of stay;Postoperative complication;Postoperative pain score;

Countries

China

Contacts

Public ContactYueying Zhang

The Affiliated Hospital of Xuzhou Medical University

zyy0218@126.com+86 180 5226 8602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026